XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK-BASED COMPENSATION AND STOCK REPURCHASE PROGRAM (Tables)
 12 Months Ended
Sep. 30, 2023
Stock-Based Compensation and Stock Repurchase Program [Abstract]  
Schedule of Stock Option Activity The following is a summary of the status of the Company’s stock option activity and related information for its option plan for the year ended September 30, 2023:
   Shares  Weighted
Average
Exercise Price		  Weighted
Average
Remaining
Contractual Life
in Years		  Aggregate
Intrinsic
Value
             
Balance at September 30, 2022   293,200   $12.58    9.98   $
—
 
Granted   
—
    
—
    
—
    
—
 
Exercised   
—
    
—
    
—
    
—
 
Forfeited   
—
    
—
    
—
    
—
 
Expired   
—
    
—
    
—
    
—
 
Balance at September 30, 2023   293,200   $12.58    8.98   $
—
 
                     
Exercisable at September 30, 2023   58,640   $12.58    8.98   $
—
 
Schedule of Non-vested Restricted Shares The following is a summary of the status of the Company’s non-vested restricted shares as of September 30, 2023 and 2022, and changes during those years:
   Shares  Weighted
Average Grant
Date Fair Value
Balance at September 30, 2022   156,400   $12.63 
Granted   
—
    
—
 
Vested   (32,080)   12.63 
Forfeited   
—
    
—
 
Balance at September 30, 2023   124,320   $12.63 
Schedule of Components of the ESOP Shares The following table presents the components of the ESOP shares for the years ended September 30, 2023 and 2022:
Unreleased shares at September 30, 2021   304,377 
Shares released for allocation during the year ended September 30, 2022   (10,427)
Shares purchased by ESOP trustee during the year ended September 30, 2022   8,423 
Unreleased shares at September 30, 2022   302,373 
Shares released for allocation during the year ended September 30, 2023   (12,060)
Shares purchased by ESOP trustee during the year ended September 30, 2023   
—
 
Unreleased shares at September 30, 2023   290,313 
Total released shares   182,485 
      
Total ESOP shares   472,798